Galectin Therapeutics Could Triple On Fibrosis And Cirrhosis Treatment By: Benzinga via Benzinga September 21, 2015 at 10:13 AM EDT Shares of Galectin Therapeutics, Inc. (NASDAQ: GALT) have declined more than 32 percent year-to-date. HC Wainwright’s ... Read More >> Related Stocks: Galectin Therapeutic